CAHILL FINANCIAL ADVISORS INC

Position in ABBV — AbbVie Inc.

CIK 1600327 EDINA, MN

Position in ABBV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$692,764

+$107,499 QoQ

Shares Held

2,753

+2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#2,881

of 4,153 holders

Holding Since

Sep 2021

8 quarters on record

Voting authority Sole 12% Shared 0% None 88%

Healthcare · as of Jun 30, 2026

CAHILL FINANCIAL ADVISORS INC holds $3,643,630 across 6 Drug Manufacturers - General names. ABBV ranks #2 (19.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,966	$1,261,215
2	ABBV	AbbVie Inc. This page	2,753	$692,764
3	MRK	Merck & Co., Inc.	4,446	$571,311
4	GILD	Gilead Sciences, Inc.	3,540	$447,243
5	AMGN	Amgen Inc	956	$346,186
6	PFE	Pfizer Inc	13,493	$324,911

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$692,764	2,753	+2.3%	Shares	Sole	2026-08-11
2026-03-31	$585,265	2,691	-0.7%	Shares	Sole	2026-05-13
2025-12-31	$618,979	2,709	-11.1%	Shares	Sole	2026-02-18
2025-09-30	$705,270	3,046	+8.2%	Shares	Sole	2025-11-03
2025-06-30	$522,520	2,815	-5.5%	Shares	Sole	2025-08-07
2025-03-31	$624,160	2,979	+5.7%	Shares	Sole	2025-05-15
2024-12-31	$500,936	2,819	+2394.7%	Shares	Sole	2025-02-14
2021-09-30	$12,189	113	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.